Crowdonomics
WatchlistPortfolio
Speranza Therapeutics

Reg CF · Common Stock · Mar 2022

WithdrawnReached targetReg CFCommon Equity
via StartEngineView campaign
Raised
$56.4K / $1.1M max
5% of ceiling · target hit day 51
Investors
2
$28.2K avg
Post-money valuation
$76.8M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$56K$28K$0
1370
Mar 14, 2022 · openedSep 12, 2022 · last reading
Target ($10K) hit — May 4, 2022, day 51Deadline Aug 1, 2022

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2020 · hover for source
$790K
$1.6M
FY2020
RevenueNet income
Metric
FY2020 reviewed*
Income statement
Revenue
$789,775
Cost of goods sold
$518,475
Gross margin
34%
Net income
$1,594,376
Taxes paid
$12,177
Balance sheet
Cash
$32,002
Accounts receivable
$129,134
Total assets
$1,532,092
Short-term debt
$869,977
Long-term debt
$0
Total liabilities
$869,977
Other
Headcount
8

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

3 amendments
  1. May 31, 2022
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  2. Apr 28, 2022
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  3. Mar 31, 2022
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$76.7M
Post-money$76.8M
Price / share$6.89
Shares offered1,451

Perks

Invest within the first week and receive 15% bonus shares · until Mar 20, 202215% bonus

Offering details

Target$9,997
Max$1,069,996
Min investment$599
OpenedMar 14, 2022
DeadlineAug 1, 2022
ClosedSep 12, 2022
Days active182

Links & provenance

Campaign pageSEC filing
Source: Manual
0001665160-22-000423

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.